Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1605, 2007-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
FDA reviews safety of somatropin
Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. :
US FDA reviewing safety of orlistat
Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. :
US FDA reviews safety of Stalevo
Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. :